… the outcome of non-small cell lung cancer (NSCLC) treated by neoadjuvant therapy has not
… to assess a novel histopathological evaluation method for predicting the outcome of NSCLC …

… the outcome of NSCLC treated by neoadjuvant therapy has been fully assessed. The … was
to assess a novel histopathological evaluation method for predicting the outcome of NSCLC …

… more efficient clinical trials incorporating novel neoadjuvant therapies that would evaluate
response as a surrogate marker for improved long-term outcomes. This strategy would allow …

… review examined histology as a potential prognostic and/or predictive factor of clinical
outcomes … In the tables presented in this review, the results for prognostic factors are reported …

… features can predict the prognosis of lung cancer patients and … Our methods are extensible
to histopathology images of … lung cancers with different survival outcomes, discover novel …

… We recently developed a novel multiscale network to avoid this … pathological images to
predict MPR and the prognosis of patients with resected NSCLC following NAT. Our results …

… that affect and predict the survival outcome of patients with … of assessing protein expression
changes in histopathology. … cancer types, and novel antiangiogenic agents have recently …

… The ir-PPS provides a novel imaging biomarker that may help select optimal … results
demonstrate that it is possible to predict progression using features extracted from histopathological …

… Surgical resection is the treatment of choice in patients with localized non-small cell lung …
period needed to evaluate novel chemotherapeutic and biologic therapies in clinical trials. …

… or prognostic factor for pathological stage I NSCLC patients from … result, we showed the
GNRI is a novel predictive and prognostic factor in surgically resected patients with pathological …